![Adora Ndu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Adora Ndu
Director/Board Member at
DBV TECHNOLOGIES
Net worth: 719 943 $ as of 31/05/2026
Profile
Dr. Adora Ndu is a VP-World Wide Research & Development at BioMarin Pharmaceutical, Inc. She is on the Board of Directors at DBV Technologies SA. Dr. Ndu was previously employed as a Member by University of Maryland. She received her graduate degree from The University of Maryland Francis King Carey School of Law and a doctorate degree from Howard University College of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 29/05/2026 | 32,908 ( 0.02% ) | 712 787 $ | 31/05/2026 | |
| 15/04/2026 | 1,825 ( 0% ) | 7 156 $ | 31/05/2026 |
Adora Ndu active positions
| Companies | Position | Start |
|---|---|---|
| DBV TECHNOLOGIES | Director/Board Member | 19/05/2021 |
| BRIDGEBIO PHARMA, INC. | General Counsel | 01/01/2022 |
| ACADIA PHARMACEUTICALS INC. | Director/Board Member | 10/10/2022 |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Director/Board Member | - |
Former positions of Adora Ndu
| Companies | Position | End |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Chief Tech/Sci/R&D Officer | 01/01/2022 |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Corporate Officer/Principal | 01/01/2016 |
Training of Adora Ndu
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
44
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
ACADIA Pharmaceuticals, Inc.
 ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
DBV Technologies SA
 DBV Technologies SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that focuses on changing the field of immunotherapy | Health Technology |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
The University of Maryland Francis King Carey School of Law
 The University of Maryland Francis King Carey School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Howard University College of Medicine
 Howard University College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BridgeBio Pharma, Inc.
 BridgeBio Pharma, Inc. BiotechnologyHealth Technology Develops medicines for genetic diseases to patients | Health Technology |
- Stock Market
- Insiders
- Adora Ndu
